The U.S. Food and Drug Administration said on Friday it approved new labeling for Sarepta Therapeutics' gene therapy Elevidys ...
A gene therapy for Duchenne muscular dystrophy caused complications to the liver, prompting a review of its use for younger patients.
The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year.
A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight ...
Acute kidney injury (AKI) is among the most common organ failures observed in the hospital and can irrevocably alter the ...
Type 1 diabetes is an autoimmune disease in which the insulin-producing β cells in the pancreatic islets of Langerhans are ...
In this video, Barry Crittenden, MD, discusses data from the RESPONSE and ASSURE trials of patients with primary biliary cholangitis who were treated with Livzelzi, with or without prior use of ...
Background: Observational studies have suggested that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a lower risk of atrial fibrillation (AF) recurrence after catheter ablation ...
Phase III trial for KLU156 (ganaplacide/lumefantrine, or GanLum), meets primary endpoint of non-inferiority to standard of care Coartem® (artemether-lumefantrine) Demonstrates PCR-corrected cure rate ...
MPR interviewed JoAnn Pinkerton, MD, about the new FDA-approved non-hormone prescription drug for menopause symptoms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback